Please use this identifier to cite or link to this item: doi:10.22028/D291-39925
Title: miR-34a-5p as molecular hub of pathomechanisms in Huntington's disease
Author(s): Hart, Martin
Diener, Caroline
Lunkes, Laetitia
Rheinheimer, Stefanie
Krammes, Lena
Keller, Andreas
Meese, Eckart
Language: English
Title: Molecular Medicine
Volume: 29
Issue: 1
Publisher/Platform: BMC
Year of Publication: 2023
Free key words: miR-34a-5p
Huntington’s disease
NDUFA9
HIP1
TGM2
POLR2G
HD pathomechanisms
miR-based therapy
DDC notations: 610 Medicine and health
Publikation type: Journal Article
Abstract: Background Although a pivotal role of microRNA (miRNA, miR) in the pathogenesis of Huntington’s disease (HD) is increasingly recognized, the molecular functions of miRNAs in the pathomechanisms of HD await further elucidation. One of the miRNAs that have been associated with HD is miR-34a-5p, which was deregulated in the mouse R6/2 model and in human HD brain tissues. Methods The aim of our study was to demonstrate interactions between miR-34a-5p and HD associated genes. By computational means we predicted 12 801 potential target genes of miR-34a-5p. An in-silico pathway analysis revealed 22 potential miR-34a-5p target genes in the KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway “Huntington’s disease”. Results Using our high-throughput miRNA interaction reporter assay (HiTmIR) we identifed NDUFA9, TAF4B, NRF1, POLR2J2, DNALI1, HIP1, TGM2 and POLR2G as direct miR-34a-5p target genes. Direct binding of miR-34a-5p to target sites in the 3’UTRs of TAF4B, NDUFA9, HIP1 and NRF1 was verifed by a mutagenesis HiTmIR assay and by determining endogenous protein levels for HIP1 and NDUFA9. STRING (Search Tool for the Retrieval of Interacting Genes/Proteins) analysis identifed protein–protein interaction networks associated with HD like “Glutamine Receptor Signaling Pathway” and “Calcium Ion Transmembrane Import Into Cytosol”. Conclusion Our study demonstrates multiple interactions between miR-34a-5p and HD associated target genes and thereby lays the ground for future therapeutic interventions using this miRNA.
DOI of the first publication: 10.1186/s10020-023-00640-7
URL of the first publication: https://molmed.biomedcentral.com/articles/10.1186/s10020-023-00640-7
Link to this record: urn:nbn:de:bsz:291--ds-399252
hdl:20.500.11880/35931
http://dx.doi.org/10.22028/D291-39925
ISSN: 1528-3658
Date of registration: 7-Jun-2023
Description of the related object: Supplementary Information
Related object: https://static-content.springer.com/esm/art%3A10.1186%2Fs10020-023-00640-7/MediaObjects/10020_2023_640_MOESM1_ESM.tif
https://static-content.springer.com/esm/art%3A10.1186%2Fs10020-023-00640-7/MediaObjects/10020_2023_640_MOESM2_ESM.tif
https://static-content.springer.com/esm/art%3A10.1186%2Fs10020-023-00640-7/MediaObjects/10020_2023_640_MOESM3_ESM.tif
https://static-content.springer.com/esm/art%3A10.1186%2Fs10020-023-00640-7/MediaObjects/10020_2023_640_MOESM4_ESM.xlsx
https://static-content.springer.com/esm/art%3A10.1186%2Fs10020-023-00640-7/MediaObjects/10020_2023_640_MOESM5_ESM.xlsx
https://static-content.springer.com/esm/art%3A10.1186%2Fs10020-023-00640-7/MediaObjects/10020_2023_640_MOESM6_ESM.xlsx
https://static-content.springer.com/esm/art%3A10.1186%2Fs10020-023-00640-7/MediaObjects/10020_2023_640_MOESM7_ESM.xlsx
https://static-content.springer.com/esm/art%3A10.1186%2Fs10020-023-00640-7/MediaObjects/10020_2023_640_MOESM8_ESM.xlsx
https://static-content.springer.com/esm/art%3A10.1186%2Fs10020-023-00640-7/MediaObjects/10020_2023_640_MOESM9_ESM.xlsx
Faculty: M - Medizinische Fakultät
Department: M - Humangenetik
M - Medizinische Biometrie, Epidemiologie und medizinische Informatik
Professorship: M - Univ.-Prof. Dr. Andreas Keller
M - Prof. Dr. Eckhart Meese
Collections:SciDok - Der Wissenschaftsserver der Universität des Saarlandes

Files for this record:
File Description SizeFormat 
s10020-023-00640-7.pdf3,7 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons